NZ203798A - Olefinic benzimidazole derivatives and pharmaceutical formulations - Google Patents

Olefinic benzimidazole derivatives and pharmaceutical formulations

Info

Publication number
NZ203798A
NZ203798A NZ203798A NZ20379883A NZ203798A NZ 203798 A NZ203798 A NZ 203798A NZ 203798 A NZ203798 A NZ 203798A NZ 20379883 A NZ20379883 A NZ 20379883A NZ 203798 A NZ203798 A NZ 203798A
Authority
NZ
New Zealand
Prior art keywords
benzimidazole
formula
amino
compounds
hydrogen
Prior art date
Application number
NZ203798A
Other languages
English (en)
Inventor
T M Morwick
C J Paget
J H Wikel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NZ203798A publication Critical patent/NZ203798A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ203798A 1982-04-08 1983-04-06 Olefinic benzimidazole derivatives and pharmaceutical formulations NZ203798A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/366,760 US4420479A (en) 1982-04-08 1982-04-08 Olefinic benzimidazoles, formulations, and antiviral methods

Publications (1)

Publication Number Publication Date
NZ203798A true NZ203798A (en) 1985-07-12

Family

ID=23444387

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ203798A NZ203798A (en) 1982-04-08 1983-04-06 Olefinic benzimidazole derivatives and pharmaceutical formulations

Country Status (18)

Country Link
US (1) US4420479A (OSRAM)
EP (1) EP0091795A1 (OSRAM)
KR (1) KR840004409A (OSRAM)
AU (1) AU1322483A (OSRAM)
CA (1) CA1197245A (OSRAM)
DD (1) DD209624A5 (OSRAM)
DK (1) DK152883A (OSRAM)
ES (2) ES8502097A1 (OSRAM)
FI (1) FI831191L (OSRAM)
GB (1) GB2119789B (OSRAM)
GR (1) GR78168B (OSRAM)
IL (1) IL68299A0 (OSRAM)
NZ (1) NZ203798A (OSRAM)
PH (1) PH18108A (OSRAM)
PL (3) PL247908A1 (OSRAM)
PT (1) PT76499B (OSRAM)
RO (1) RO86319B (OSRAM)
ZA (1) ZA832410B (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0494405T3 (da) * 1991-01-10 1996-11-18 Transcend Therapeutics Inc Anvendelse af thiazolidin-4-carboxylatderivater til behandling af lungesygdomme
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US5605919A (en) * 1993-02-26 1997-02-25 Takeda Chemical Industries, Ltd. Treatment for viral diseases
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
US5475109A (en) * 1994-10-17 1995-12-12 Merck & Co., Inc. Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease
US5693661A (en) * 1995-06-07 1997-12-02 Eli Lilly And Company Anti-viral compounds
US5545653A (en) * 1995-06-07 1996-08-13 Eli Lilly And Company Anti-viral compounds
KR20000016346A (ko) * 1996-06-05 2000-03-25 피터 지. 스트링거 항바이러스성 화합물
US5891874A (en) * 1996-06-05 1999-04-06 Eli Lilly And Company Anti-viral compound
US5821242A (en) * 1996-06-06 1998-10-13 Eli Lilly And Company Anti-viral compounds
FI990180L (fi) 1996-08-12 1999-03-08 Celgene Corp Uusia immunoterapeuttisia aineita ja niiden käyttö sytokiini-tasojen pienentämiseksi
WO1998031363A1 (en) * 1997-01-22 1998-07-23 Eli Lilly And Company Anti-viral compounds
JP2002503253A (ja) * 1997-06-04 2002-01-29 イーライ・リリー・アンド・カンパニー 抗ウイルス化合物
US7470723B2 (en) 2003-03-05 2008-12-30 Celgene Corporation Diphenylethylene compounds and uses thereof
AU2004218364A1 (en) 2003-03-05 2004-09-16 Celgene Corporation Diphenylethylene compounds and uses thereof
AU2005282727A1 (en) 2004-09-03 2006-03-16 Celgene Corporation Substituted heterocyclic compounds and uses thereof
CN108997158B (zh) * 2018-07-16 2020-12-15 青岛科技大学 一种实现二取代酰胺与二苯基甲酮偶联的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018790A (en) * 1975-05-08 1977-04-19 Eli Lilly And Company Substituted 1-sulfonylbenzimidazoles
MX3654E (es) * 1975-08-28 1981-04-14 Lilly Co Eli Procedimiento para preparar compuestos de sulfonilbencimidazol
US4174454A (en) * 1975-08-28 1979-11-13 Eli Lilly And Company Alkylidenylmethyl-substituted 1-sulfonylbenzimidazoles
CA1076582A (en) * 1975-10-28 1980-04-29 Charles J. Paget Antiviral thiazolinyl or thiazinyl ketobenzimidazoles
US4008243A (en) * 1975-11-19 1977-02-15 Eli Lilly And Company Antiviral thiazolinyl or thiazinyl benzimidazole esters
US4118573A (en) * 1975-11-24 1978-10-03 Eli Lilly And Company Substituted 1-sulfonylbenzimidazoles
GR66420B (OSRAM) * 1976-12-15 1981-03-20 Lilly Co Eli
US4230868A (en) * 1979-04-17 1980-10-28 Eli Lilly And Company α-Alkyl-α-hydroxybenzyl-substituted 1-sulfonylbenzimidazoles
US4316021A (en) * 1979-08-13 1982-02-16 Eli Lilly And Company Substituted 1-sulfonylbenzimidazoles

Also Published As

Publication number Publication date
ES534218A0 (es) 1985-06-01
PH18108A (en) 1985-03-22
RO86319A (ro) 1985-03-15
DK152883D0 (da) 1983-04-06
RO86319B (ro) 1985-03-31
PT76499B (en) 1986-03-18
GB2119789A (en) 1983-11-23
GB2119789B (en) 1985-08-29
FI831191A7 (fi) 1983-10-09
FI831191L (fi) 1983-10-09
IL68299A0 (en) 1983-07-31
DD209624A5 (de) 1984-05-16
AU1322483A (en) 1983-10-13
GR78168B (OSRAM) 1984-09-26
US4420479A (en) 1983-12-13
EP0091795A1 (en) 1983-10-19
PL247909A1 (en) 1984-12-17
FI831191A0 (fi) 1983-04-08
ES521318A0 (es) 1984-12-16
KR840004409A (ko) 1984-10-15
DK152883A (da) 1983-10-09
CA1197245A (en) 1985-11-26
PL241385A1 (en) 1984-09-24
ES8505966A1 (es) 1985-06-01
ES8502097A1 (es) 1984-12-16
PL247908A1 (en) 1985-01-16
ZA832410B (en) 1984-11-28
PT76499A (en) 1983-05-01

Similar Documents

Publication Publication Date Title
NZ203798A (en) Olefinic benzimidazole derivatives and pharmaceutical formulations
AU2002324582B2 (en) Novel gamma secretase inhibitors
EP0022317B1 (en) 2-oxo-benzothiazoline, benzoxazoline or indoline derivatives, their preparation, and pharmaceutical compositions comprising such derivatives
SU986297A3 (ru) Способ получени производных 5-/4-диарилметил/-1-пиперазинилалкилбензимидазола или их солей
HU196971B (en) Process for producing new benzimidazol derivatives and pharmaceutical compositions containing them
NZ328900A (en) Substituted phenyl or pyridyl substituted phenyl, benzo[b]furan or indolyl derivatives and medicaments
CZ290784B6 (cs) Pyrido[3,2-e]pyrazinony, způsoby jejich výroby a pouľití a farmaceutické přípravky na jejich bázi
CZ293825B6 (cs) ChinoxalinyŹ způsob jejich výroby a jejich použití a farmaceutické prostředky tyto látky obsahující
JP2005521689A (ja) Atm阻害剤として有用なピラノン
JPS61207374A (ja) 新規化合物および医薬組成物
HU199791B (en) Process for producing carboxamides comprising indolyl and indazolyl group
US6391891B1 (en) Bicyclic compounds as ligands for 5-HT1 receptors
GB1562812A (en) 1-sulphonyl-2-(amino or acylamino)-benzimidazoles
US5190956A (en) Certain N-substituted 3-oximino-2,4-dioxoquinolin-2,4-(1H)diones useful for treating viral infections
US4438126A (en) Lower alkanoic acid derivatives of 2-oxo-benzoxazolines and aldose reductase inhibiting compositions thereof
RU2001911C1 (ru) Способ получени замещенных 1,2,3,4-тетрагидронафталинов или их фармацевтически приемлемых аддитивных солей кислоты
JPH03503889A (ja) PAF拮抗剤としての1H/3H‐[4‐(N,N‐ジシクロアルキル/分枝アルキルカルボキサミド)‐ベンジル]イミダゾ[4,5‐c]ピリジン類
US4150028A (en) Antiviral thiazolinyl benzimidazoles
US3910955A (en) Benzothiophene-ethylamines
FR2891829A1 (fr) Derives de la 4-amino-quinazoline, leur preparation et leur application en therapeutique
PL150841B1 (en) Purine compounds.
US6025390A (en) Heteroaromatic pentadienoic acid derivatives useful as inhibitors of bone resorption
US4230868A (en) α-Alkyl-α-hydroxybenzyl-substituted 1-sulfonylbenzimidazoles
JPS58188868A (ja) オレフイン系ベンズイミダゾ−ル類
US4338315A (en) Antiviral method employing thiazinyl benzimidazole derivatives